BACKGROUND: Metamizole (dipyrone) is a myelotoxic, nonsteroidal anti-inflammatory agent that has been banned from the US market since 1979. However, dipyrone may be purchased in some areas of the US. We conducted a survey in a primary care setting in Miami, Florida to determine the prevalence of metamizole possession and use among Hispanics living in this area. METHODS: Participants consisted of 137 Hispanic outpatients interviewed consecutively during a primary care visit in the month of February 2005. RESULTS: Metamizole was possessed by 28% of the surveyed population. The most common reasons for using dipyrone were pain (72%) and fever (24%). The vast majority of patients had purchased the medication in Latin America (95%), in most instances without a prescription (95%). Nineteen patients (13%) had used the medication during the previous year. CONCLUSIONS: Metamizole is available to Latino immigrants who reside in the US, despite the FDA ban imposed in 1977.
|Original language||English (US)|
|Number of pages||3|
|Journal||Southern Medical Journal|
|State||Published - Sep 2006|
- Hispanic Americans